Skip to main content
Drug Metabolism Letters publishes short papers on major advances in all areas of drug metabolism and disposition. The emphasis will be on publishing quality papers very rapidly. Letters will be processed rapidly by taking full advantage of the Internet technology for both the submission and review of manuscripts. The journal covers the following areas:

In vitro systems including CYP-450; enzyme induction and inhibition; drug-drug interactions and enzyme kinetics; pharmacokinetics, toxicokinetics, species scaling and extrapolations; P-glycoprotein and transport carriers; target organ toxicity and interindividual variability; drug metabolism and disposition studies; extrahepatic metabolism; phase I and phase II metabolism; recent developments for the identification of drug metabolites, reactive intermediate and glutathione conjugates.

Publisher: Bentham Science Publishers

More about this publication?
Volume 12, Number 1, 2018

Articles

Free Content Graphical Abstracts
pp. i-v(5)

Favourites:
ADD

Free Content Meet Our Editorial Board Member
pp. 1-1(1)
Author: Sinz, Michael

Favourites:
ADD

Preface

Free Content Preface
pp. 2-2(1)
Author: Balani, Suresh

Favourites:
ADD

Research article

Utility of Pooled Cryopreserved Human Enterocytes as an In vitro Model for Assessing Intestinal Clearance and Drug-Drug Interactions
pp. 3-13(11)
Authors: Wong, Susan; Doshi, Utkarsh; Vuong, Peter; Liu, Ning; Tay, Suzanne; Le, Hoa; Kosaka, Mika; Kenny, Jane R.; Li, Albert P.; Yan, Zhengyin

Favourites:
ADD

Cytochrome P450 1A2 Messenger RNA is a More Reliable Marker than Cytochrome P450 1A2 Activity, Phenacetin O-Deethylation, for Assessment of Induction Potential of Drug-Metabolizing Enzymes Using HepaRG Cells
pp. 14-23(10)
Authors: Ogasawara, Akira; Kato, Nozomu; Torimoto, Nao; Aohara, Fumika; Ohashi, Rikiya; Yamada, Yasuhiro; Taniguchi, Hideki

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

LC-MS/MS Identification and Structural Characterization of Main Biodegradation Products of Nitroproston - A Novel Prostaglandin-based Pharmaceutical Compound
pp. 54-61(8)
Authors: Mesonzhnik, Natalia V.; Moskaleva, Natalia E.; Shestakova, Ksenia M.; Kurynina, Ksenya O.; Baranov, Pavel A.; Gretskaya, Natalia M.; Serkov, Igor V.; Lyubimov, Igor I.; Bezuglov, Vladimir V.; Appolonova, Svetlana A.

Favourites:
ADD

Evaluation of Herb-Drug Interaction of Synacinn™ and Individual Biomarker through Cytochrome 450 Inhibition Assay
pp. 62-67(6)
Authors: Ab Rahman, Nur S.; Abd Majid, Fadzilah Adibah; Abd Wahid, Mohd Effendy; Zainudin, Ain Nabihah; Zainol, Siti Nurazwa; Ismail, Hassan Fahmi; Wong, Tet Soon; Tiwari, Nirbhay Kumar; Giri, Sanjeev; Bhargava, Vijaya

Favourites:
ADD

Effect of CYP2D6 Poor Metabolizer Phenotype on Stereoselective Nebivolol Pharmacokinetics
pp. 68-70(3)
Authors: Vieira, Carolina P.; Neves, Daniel V.; Coelho, Eduardo B.; Lanchote, Vera L.

Favourites:
ADD

Case report

Articles

Open Access Evaluation of the Effect of Uremic Serum on Hepatic Reductase Functional Expression
pp. 75-81(7)
Authors: Alshogran, Osama Y.; Al-Obaidi, Esra'a F.; Al-Husein, Belal A.; Oweis, Ashraf O.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content